Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration [Phase 2]
QA108 in subjects with intermediate age-related macular degeneration has completed its Phase II study.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Etude de l'ANesthésie Par Gel de Lidocaïne Pour Les Injections IntrA vitréennes
A completed clinical trial evaluated lidocaine gel as topical anesthesia for intravitreal injections in retinal diseases, including age-rela…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation [EARLY_Phase 1]
An early Phase 1 study evaluating vitamin A palmitate supplementation in patients with Reticular Pseudodrusen and delayed dark adaptation, w…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB) [Phase 2, Phase 3]
A clinical trial update shows LumiThera's LIGHTSITE IIIB study for dry age-related macular degeneration is in Phase 2/3 and is currently act…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD [NA]
This clinical trial update notes the completion of a study evaluating omega-3 fatty acids and vitamin D dosing in people at moderate to high…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy [Phase 2]
This Phase 2 clinical trial update covers long-term follow-up of RGX-314 in neovascular age-related macular degeneration, including a fellow…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration [Phase 3]
Phase 3 study evaluating the effects of brolucizumab in adults with neovascular age-related macular degeneration has completed and posted re…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Efficacy of Retreatments With Intravitreal Bevacizumab [Phase 3]
Phase 3 trial evaluating retreatments with intravitreal bevacizumab for age-related macular degeneration has been terminated; no final effic…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation [EARLY_Phase 1]
This early-phase trial evaluated vitamin A palmitate supplementation in people with age-related macular degeneration (without reticular pseu…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Intravitreal Bevacizumab for Age-Related Macular Degeneration [Phase 2]
Phase 2 trial evaluating intravitreal bevacizumab for age-related macular degeneration has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Validation of Bulbicam for DR- and AMD-patients
This clinical trial update reports the completion of validation studies for Bulbicam in patients with diabetic retinopathy and age-related m…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC
The study evaluating deep learning analysis of OCT and OCTA for neovascularization in age-related macular degeneration has completed. It dis…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E [Phase 4]
This clinical trial update reports results from a Phase 4 study evaluating Brolocizumab with immediate Treat-and-Extend dosing for recalcitr…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort) [NA]
The Dijon 3C Montrachet Cohort observational study examining signs of ocular degeneration in age-related macular degeneration and glaucoma h…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Carbidopa-Levodopa in Dry AMD With Geographic Atrophy [Phase 2]
Phase 2 clinical trial evaluating carbidopa-levodopa for dry age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Visual Function Tests in Age-related Macular Degeneration
The clinical trial evaluating visual function tests in age-related macular degeneration has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration [Phase 1, Phase 2]
Phase 1/2 clinical trial update for VOY-101 in advanced non-neovascular age-related macular degeneration and geographic atrophy.
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual Acuity [Phase 4]
Phase 4 trial update evaluating visual function changes in wet age-related macular degeneration patients with better baseline visual acuity.
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study [Phase 2]
A Phase 2 long-term follow-up study evaluating the safety of GT005 in participants with geographic atrophy secondary to age-related macular …
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: A Study to Investigate the Effect on Central Macular Thickness of Treatment With MG-O-1002 Eye Drops in Participants Aged Over 45 With Neovascular Age-related Macular Degeneration (nAMD) [Phase 2]
Phase 2 clinical trial evaluating MG-O-1002 eye drops for reducing central macular thickness in participants over 45 with neovascular age-re…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration [Phase 2]
Phase 2 trial results update evaluating oral minocycline for geographic atrophy in age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) [Phase 3]
A Phase 3 TALON study comparing brolucizumab 6 mg to aflibercept 2 mg in a treat-to-control regimen for age-related macular degeneration has…
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Clinical Evaluation of VeriSee AMD in Screening for Age-Related Macular Degeneration
A completed clinical trial evaluating VeriSee AMD for screening age-related macular degeneration; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2023-12-28Clinical Trial Update: A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) [Phase 3]
Phase 3 safety and efficacy study of intravitreal Zimura (avacincaptad pegol) for geographic atrophy and age-related macular degeneration ha…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD [Phase 3]
Phase 3 trial comparing biosimilar Xlucane to Lucentis in neovascular age-related macular degeneration has completed; results posted.